Clinical Researcher—March 2021 (Volume 35, Issue 2) CHAIR’S MESSAGE Erika Stevens, MA Does the clinical trial industry need to do more to professionalize itself? While the clinical research enterprise […]
Clinical Researcher—March 2021 (Volume 35, Issue 2) THE LEGAL LANDSCAPE Robert King With more than a million lawyers working in the United States and a quarter million deaths caused […]
Clinical Researcher—March 2021 (Volume 35, Issue 2) OVER THE TRANSOM Gary W. Cramer As I write this, I have very recently observed my 15th anniversary of working for ACRP […]
Clinical Researcher—January 2021 (Volume 35, Issue 1) PEER REVIEWED Wasi Akhtar, BPharm, MBA Biosimilars, even though they are newer versions of existing, trade-name biological products whose patents have expired […]
Clinical Researcher—January 2021 (Volume 35, Issue 1) PEER REVIEWED Mary Costello Change is never easy, and this past year has presented the world with some seemingly insurmountable challenges—certainly among […]